Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence"

Drug Saf. 2018 Oct;41(10):995-997. doi: 10.1007/s40264-018-0692-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Delayed-Action Preparations
  • Humans
  • Naltrexone*
  • Opioid-Related Disorders*

Substances

  • Delayed-Action Preparations
  • Naltrexone